MA
XENT

MUFG Americas’s Intersect ENT, Inc XENT Stock Holding History

MUFG Americas’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-273
Closed -$9K – 936
2019
Q1 		$9K Buy
+273
New +$8.45K ﹤0.01% 809
2018
Q3 		– Sell
-350
Closed -$13K – 864
2018
Q2 		$13K Hold
350
– – ﹤0.01% 738
2018
Q1 		$14K Sell
350
-365
-51% -$13.3K ﹤0.01% 728
2017
Q4 		$23K Buy
715
+580
+430% +$17.4K ﹤0.01% 714
2017
Q3 		$4K Buy
135
+46
+52% +$1.36K ﹤0.01% 976
2017
Q2 		$2K Buy
+89
New +$2.02K ﹤0.01% 1085
2015
Q4 		– Sell
-325
Closed -$8K – 1247
2015
Q3 		$8K Buy
+325
New +$8.97K ﹤0.01% 908

Other funds holding XENT

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

MUFG Americas's XENT Position: Q2 2019 in Review

MUFG Americas sold out of Intersect ENT, Inc (XENT) in Q2 2019, closing a stake of 273 shares — an estimated $9K sold.

MUFG Americas first reported a position in XENT in Q3 2015 and held it in 7 quarters. The position peaked at $23K in Q4 2017. 112 funds tracked by Wall St. Rank hold XENT as of Q2 2019.

  • MUFG Americas reported no remaining Intersect ENT, Inc position as of Q2 2019 after selling out during the quarter.
  • MUFG Americas sold 273 Intersect ENT, Inc shares in Q2 2019, an estimated $9K.
  • MUFG Americas first reported a position in Intersect ENT, Inc in Q3 2015 and held it in 7 quarters.
  • MUFG Americas's Intersect ENT, Inc position peaked at $23K in Q4 2017.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2019.

Based on MUFG Americas's 13F filing for Q2 2019, filed 9 Aug 2019.